RE:Catalysts.I agree. We as a company will not be around for the commercialization event as we are a buyout story on successful human trials! We are a research and development company in the medical field that will nurture this process to a point where others like big pharma will take control and either shelve it or allow it in the cancer market.
Same thing happens in the mining industry, a resource development company advances a mineral project so far that their expertise is not in production or operating a mine but to sell it off to majors who can finance its operations and manufacture a final product to market.
Theralase will become a target, I just hope Roger can reject offers until phase 2 trial results are known and not sell premature during phase 1 as excitement and value will build further in the drug development process.